Multi-Omics Approach Reveals Prebiotic and Potential Antioxidant Effects of Essential Oils from the Mediterranean Diet on Cardiometabolic Disorder Using Humanized Gnotobiotic Mice
暂无分享,去创建一个
M. Murri | M. Queipo-Ortuño | M. Crespo-Leiro | M. Jiménez-Navarro | M. Estévez | A. González-Jiménez | J. Delgado | V. Becerra-Muñoz | J. Rodríguez-Capitán | Dina Medina-Vera | F.J. Pavón-Morón | Isaac J. Plaza-Andrades | M. Sánchez-Quintero | Laura Martín Chaves | Guillermo Paz López | Juan A. G. Ranea | M. I. Queipo-Ortuño | D. Medina-Vera | A. Gonzalez-Jimenez
[1] A. Gasparotto Junior,et al. Natural Products as Modulators of Mitochondrial Dysfunctions Associated with Cardiovascular Diseases: Advances and Opportunities. , 2023, Journal of medicinal food.
[2] Xinchun Yang,et al. Untargeted metabolomics unravel serum metabolic alterations in smokers with hypertension , 2023, Frontiers in Physiology.
[3] E. Lucchi,et al. Plant Essential Oils as Healthy Functional Ingredients of Nutraceuticals and Diet Supplements: A Review , 2023, Molecules.
[4] C. Maack,et al. Mitochondrial Effects of Common Cardiovascular Medications: The Good, the Bad and the Mixed , 2022, International journal of molecular sciences.
[5] M. Queipo-Ortuño,et al. Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus , 2022, Nutrients.
[6] Xiangfang Yu,et al. Perturbation on gut microbiota impedes the onset of obesity in high fat diet-induced mice , 2022, Frontiers in Endocrinology.
[7] K. Liang,et al. Lower All-Cause Mortality for Coronary Heart or Stroke Patients Who Adhere Better to Mediterranean Diet-An NHANES Analysis , 2022, Nutrients.
[8] Xiaofang Jiang,et al. Preclinical Studies of Natural Products Targeting the Gut Microbiota: Beneficial Effects on Diabetes. , 2022, Journal of agricultural and food chemistry.
[9] J. Chalovich,et al. Hypertrophic Cardiomyopathy Mutations of Troponin Reveal Details of Striated Muscle Regulation , 2022, Frontiers in Physiology.
[10] G. Deco,et al. Microbiota alterations in proline metabolism impact depression. , 2022, Cell metabolism.
[11] I. Gould,et al. Modulation of cardiac thin filament structure by phosphorylated troponin-I analyzed by protein-protein docking and molecular dynamics simulation. , 2022, Archives of biochemistry and biophysics.
[12] Lanjuan Li,et al. Akkermansia muciniphila Ameliorates Acetaminophen-Induced Liver Injury by Regulating Gut Microbial Composition and Metabolism , 2022, Microbiology spectrum.
[13] S. Müller,et al. SUMO-specific Isopeptidases Tuning Cardiac SUMOylation in Health and Disease , 2021, Frontiers in Molecular Biosciences.
[14] R. Martínez,et al. Protein carbonylation in food and nutrition: a concise update , 2021, Amino Acids.
[15] L. Pieters,et al. Natural Products as a Source of Inspiration for Novel Inhibitors of Advanced Glycation Endproducts (AGEs) Formation , 2021, Planta Medica.
[16] J. Tanner,et al. Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target , 2021, Amino Acids.
[17] P. Kralickova,et al. Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions , 2021, Microorganisms.
[18] Kathleen M. Jagodnik,et al. Gene Set Knowledge Discovery with Enrichr , 2021, Current protocols.
[19] C. Luna,et al. Allysine and α-Aminoadipic Acid as Markers of the Glyco-Oxidative Damage to Human Serum Albumin under Pathological Glucose Concentrations , 2021, Antioxidants.
[20] B. Udd,et al. Panorama of the distal myopathies , 2020, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[21] Xianwei Wang,et al. ROS systems are a new integrated network for sensing homeostasis and alarming stresses in organelle metabolic processes , 2020, Redox biology.
[22] Yuan Zhang,et al. Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2 , 2019, Microbiome.
[23] E. Almogbel,et al. Elevated Levels of Protein Carbonylation in Patients With Diabetic Nephropathy: Therapeutic and Diagnostic Prospects. , 2019, The American journal of the medical sciences.
[24] Siyi Pan,et al. Effects of orange essential oil on intestinal microflora in mice. , 2019, Journal of the science of food and agriculture.
[25] Boris Lamp,et al. The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes , 2019, Nature Communications.
[26] Elizabeth A. Kennedy,et al. Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria , 2018, Front. Physiol..
[27] F. Melchior,et al. Control of SUMO and Ubiquitin by ROS: Signaling and disease implications. , 2018, Molecular aspects of medicine.
[28] Amin Mousavi Khaneghah,et al. The effects of food essential oils on cardiovascular diseases: A review , 2018, Critical reviews in food science and nutrition.
[29] G. Corrêa Souza,et al. Dietary Patterns in Secondary Prevention of Heart Failure: A Systematic Review , 2018, Nutrients.
[30] M. Hernán,et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra‐Virgin Olive Oil or Nuts , 2018, The New England journal of medicine.
[31] C. Alcántara,et al. Shifts on Gut Microbiota Associated to Mediterranean Diet Adherence and Specific Dietary Intakes on General Adult Population , 2018, Front. Microbiol..
[32] Benjamin M Hillmann,et al. Fecal microbiota transplantation reverses antibiotic and chemotherapy-induced gut dysbiosis in mice , 2018, Scientific Reports.
[33] M. Hecker,et al. Role of protein carbonylation in diabetes , 2018, Journal of Inherited Metabolic Disease.
[34] Jinlan Jiang,et al. Sumoylation of SMAD 4 ameliorates the oxidative stress‐induced apoptosis in osteoblasts , 2017, Cytokine.
[35] A. Barzegari,et al. Myocardial infarction and gut microbiota: An incidental connection. , 2017, Pharmacological research.
[36] I. Moreno-Indias,et al. Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus , 2017, Front. Microbiol..
[37] J. Peng,et al. A carvacrol-thymol blend decreased intestinal oxidative stress and influenced selected microbes without changing the messenger RNA levels of tight junction proteins in jejunal mucosa of weaning piglets. , 2017, Animal : an international journal of animal bioscience.
[38] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[39] Chi-Tang Ho,et al. Dietary allicin reduces transformation of L-carnitine to TMAO through impact on gut microbiota , 2015 .
[40] H. Godoy,et al. Microencapsulated eucalyptol and eugenol as growth promoters in broilers. , 2014 .
[41] M. Blüher,et al. Carbonylated plasma proteins as potential biomarkers of obesity induced type 2 diabetes mellitus. , 2014, Journal of proteome research.
[42] T. Wolever,et al. Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans , 2014, Nutrition & Diabetes.
[43] H. Tilg,et al. Microbiota and diabetes: an evolving relationship , 2014, Gut.
[44] X. Cai,et al. Regulation of N-acetyl cysteine on gut redox status and major microbiota in weaned piglets. , 2014, Journal of animal science.
[45] H. Ping,et al. Essential Oils, A New Horizon in Combating Bacterial Antibiotic Resistance , 2014, The open microbiology journal.
[46] A. Golian,et al. Effect of thymol and carvacrol feed supplementation on performance, antioxidant enzyme activities, fatty acid composition, digestive enzyme activities, and immune response in broiler chickens. , 2013, Poultry science.
[47] Edward Y. Chen,et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.
[48] Nora C. Toussaint,et al. Intestinal Microbiota Containing Barnesiella Species Cures Vancomycin-Resistant Enterococcus faecium Colonization , 2013, Infection and Immunity.
[49] P. Ray,et al. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. , 2012, Cellular signalling.
[50] S. Y. Li,et al. The effect of essential oils on performance, immunity and gut microbial population in weaner pigs , 2012 .
[51] M. Estévez,et al. Fluorescent HPLC for the detection of specific protein oxidation carbonyls - α-aminoadipic and γ-glutamic semialdehydes - in meat systems. , 2011, Meat science.
[52] Arthur Kaser,et al. Gut microbiome, obesity, and metabolic dysfunction. , 2011, The Journal of clinical investigation.
[53] L. Meza-Zepeda,et al. Depletion of Murine Intestinal Microbiota: Effects on Gut Mucosa and Epithelial Gene Expression , 2011, PloS one.
[54] Jin Sun,et al. Lactobacilli prevent hydroxy radical production and inhibit Escherichia coli and Enterococcus growth in system mimicking colon fermentation , 2010, Letters in applied microbiology.
[55] V. Monnier,et al. 2-aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis. , 2007, The Biochemical journal.
[56] G. Macfarlane,et al. Regulation of short-chain fatty acid production , 2003, Proceedings of the Nutrition Society.
[57] T. Miller,et al. Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora , 1996, Applied and environmental microbiology.
[58] S. Chung,et al. Tissue-specific expression of two aldose reductase-like genes in mice: abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland. , 1995, The Biochemical journal.
[59] S. Lacroix,et al. Contemporary issues regarding nutrition in cardiovascular rehabilitation. , 2017, Annals of physical and rehabilitation medicine.
[60] M. Alagawany. Biological Effects and Modes of Action of Carvacrol in Animal and Poultry Production and Health - A Review , 2015 .
[61] J. Lovegrove,et al. The gut microbiota and lipid metabolism: implications for human health and coronary heart disease. , 2006, Current medicinal chemistry.